prednisone has been researched along with Central Nervous System Cysticercosis in 14 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In this trial, 178 patients with active or transitional neurocysticercosis cysts and new-onset symptoms were randomized to 8 days of treatment with albendazole (n=88) or placebo (n=90), both with prednisone, and followed for 24 months." | 9.20 | The effect of albendazole treatment on seizure outcomes in patients with symptomatic neurocysticercosis. ( Andrews, H; Bagiella, E; Carpio, A; Hauser, WA; Kelvin, EA; Leslie, D; Romo, ML; Wyka, K, 2015) |
| "The aim of this trial was to evaluate the effects of albendazole (ALB) on cyst disappearance, reduction of the number of cysts and seizure recurrence." | 9.13 | Effects of albendazole treatment on neurocysticercosis: a randomised controlled trial. ( Andrews, H; Bagiella, E; Carpio, A; Hauser, WA; Kelvin, EA; Leon, P; Leslie, D, 2008) |
| "Neurocysticercosis is the most common parasitic infection of the central nervous system." | 5.33 | Resolution of arterial stenosis in a patient with periarterial neurocysticercosis treated with oral prednisone. ( Bouldin, A; Pinter, JD, 2006) |
| "In this trial, 178 patients with active or transitional neurocysticercosis cysts and new-onset symptoms were randomized to 8 days of treatment with albendazole (n=88) or placebo (n=90), both with prednisone, and followed for 24 months." | 5.20 | The effect of albendazole treatment on seizure outcomes in patients with symptomatic neurocysticercosis. ( Andrews, H; Bagiella, E; Carpio, A; Hauser, WA; Kelvin, EA; Leslie, D; Romo, ML; Wyka, K, 2015) |
| "The aim of this trial was to evaluate the effects of albendazole (ALB) on cyst disappearance, reduction of the number of cysts and seizure recurrence." | 5.13 | Effects of albendazole treatment on neurocysticercosis: a randomised controlled trial. ( Andrews, H; Bagiella, E; Carpio, A; Hauser, WA; Kelvin, EA; Leon, P; Leslie, D, 2008) |
| "Neurocysticercosis is the most common parasitic infection of the brain." | 2.50 | Neurocysticercosis in Wisconsin: 3 cases and a review of the literature. ( Naddaf, E; Seeger, SK; Stafstrom, CE, 2014) |
| "Extraparenchymal neurocysticercosis is the most severe form of cysticercosis, and response to treatment is suboptimal." | 1.51 | Factors Associated With Cysticidal Treatment Response in Extraparenchymal Neurocysticercosis. ( Carrillo-Mezo, R; Fleury, A; González-Hernández, I; Jung, H; Matus, C; Osorio, R; Romo, ML; Toledo, A, 2019) |
| "Neurocysticercosis is the most common parasitic infection of the central nervous system." | 1.33 | Resolution of arterial stenosis in a patient with periarterial neurocysticercosis treated with oral prednisone. ( Bouldin, A; Pinter, JD, 2006) |
| "Cysticercosis is an helminthic disease which is usually observed in endemic areas or in immigrants coming from these areas." | 1.32 | [Neurocysticercosis complicating the treatment of cutaneous cysticercosis in a traveller]. ( Bricaire, E; Caumes, E; Chemali, N; Danis, M; Epelboin, L; Klement, E, 2004) |
| "A CT scan showed severe hydrocephalus and calcifications, prompting a ventriculoperitoneal shunt placement." | 1.30 | Transient hemifacial spasm associated with subarachnoid brainstem cysticercosis: a case report. ( Ramos-Peek, J; Revuelta Gutierrez, R; Soto-Hernández, JL; Suastegui-Roman, R, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 5 (35.71) | 29.6817 |
| 2010's | 7 (50.00) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Pérez-Jacoiste Asín, MA | 1 |
| Calleja-Castaño, P | 1 |
| Hilario, A | 1 |
| Thapa, K | 1 |
| Romo, ML | 3 |
| Carpio, A | 3 |
| Leslie, D | 3 |
| Andrews, H | 3 |
| Hauser, WA | 3 |
| Kelvin, EA | 3 |
| Osorio, R | 1 |
| Carrillo-Mezo, R | 1 |
| Toledo, A | 1 |
| Matus, C | 1 |
| González-Hernández, I | 1 |
| Jung, H | 1 |
| Fleury, A | 1 |
| Min, Z | 1 |
| Naddaf, E | 1 |
| Seeger, SK | 1 |
| Stafstrom, CE | 1 |
| Ramos-Zúñiga, R | 1 |
| Pérez-Gómez, HR | 1 |
| Gaytán-Martínez, LA | 1 |
| Vega-Ruiz, B | 1 |
| Soto-Rodríguez, S | 1 |
| Rochín-Mozqueda, A | 1 |
| Wyka, K | 1 |
| Bagiella, E | 2 |
| Marquez-Romero, JM | 1 |
| Santana-López, JM | 1 |
| Espinoza-López, DA | 1 |
| Zermeño, F | 1 |
| Castillo-Iglesias, H | 1 |
| Mouly, S | 1 |
| Ducros, A | 1 |
| Sarfati, C | 1 |
| Sulahian, A | 1 |
| Bergmann, JF | 1 |
| Bouldin, A | 1 |
| Pinter, JD | 1 |
| Epelboin, L | 1 |
| Klement, E | 1 |
| Chemali, N | 1 |
| Danis, M | 1 |
| Bricaire, E | 1 |
| Caumes, E | 1 |
| Leon, P | 1 |
| Revuelta Gutierrez, R | 1 |
| Soto-Hernández, JL | 1 |
| Suastegui-Roman, R | 1 |
| Ramos-Peek, J | 1 |
| Belo, M | 1 |
| Grunitzky, EK | 1 |
| Balogou, A | 1 |
| Kowu, L | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Pilot Study of Neurocysticercosis Treatment[NCT00283699] | Phase 3 | 178 participants (Actual) | Interventional | 2001-02-28 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for prednisone and Central Nervous System Cysticercosis
| Article | Year |
|---|---|
Neurocysticercosis in Wisconsin: 3 cases and a review of the literature.
Topics: Adult; Albendazole; Anthelmintics; Diagnosis, Differential; Diagnostic Imaging; Drug Therapy, Combin | 2014 |
3 trials available for prednisone and Central Nervous System Cysticercosis
| Article | Year |
|---|---|
The effect of albendazole treatment on non-seizure outcomes in patients with symptomatic neurocysticercosis.
Topics: Administration, Oral; Albendazole; Animals; Anthelmintics; Double-Blind Method; Drug Administration | 2018 |
The effect of albendazole treatment on seizure outcomes in patients with symptomatic neurocysticercosis.
Topics: Albendazole; Animals; Anthelmintics; Anti-Inflammatory Agents; Brain; Cysts; Drug Therapy, Combinati | 2015 |
Effects of albendazole treatment on neurocysticercosis: a randomised controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Albendazole; Anti-Inflammatory Agents; Antiparasitic Agents; Brain; | 2008 |
10 other studies available for prednisone and Central Nervous System Cysticercosis
| Article | Year |
|---|---|
Lumbosacral Radiculopathy as the Clinical Presentation of Neurocysticercosis.
Topics: Adult; Albendazole; Anthelmintics; Anti-Inflammatory Agents; Antibodies, Helminth; Female; Humans; I | 2020 |
Factors Associated With Cysticidal Treatment Response in Extraparenchymal Neurocysticercosis.
Topics: Adult; Age Factors; Albendazole; Anthelmintics; Dexamethasone; Drug Therapy, Combination; Female; Hu | 2019 |
Parenchymal neurocysticercosis.
Topics: Adult; Albendazole; Animals; Humans; Male; Mexican Americans; Neurocysticercosis; Prednisone; Taenia | 2015 |
[Temporal lobe epilepsy and active neurocysticercosis: two representative case reports].
Topics: Albendazole; Anomia; Anthelmintics; Anticonvulsants; Antipsychotic Agents; Carbamazepine; Citalopram | 2015 |
Conservative treatment of a ruptured inflammatory infectious aneurysm caused by neurocysticercosis.
Topics: Adult; Aneurysm, Infected; Aneurysm, Ruptured; Anti-Inflammatory Agents; Brain; Headache; Humans; In | 2012 |
Late-onset eosinophilic chronic meningitis occurring 30 years after Taenia solium infestation in a white Caucasian woman.
Topics: Albendazole; Animals; Anthelmintics; Chronic Disease; Eosinophilia; Female; Glucocorticoids; Headach | 2006 |
Resolution of arterial stenosis in a patient with periarterial neurocysticercosis treated with oral prednisone.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child; Chorea; Gadoliniu | 2006 |
[Neurocysticercosis complicating the treatment of cutaneous cysticercosis in a traveller].
Topics: Adult; Albendazole; Anthelmintics; Brain Edema; Combined Modality Therapy; Confusion; Cysticercosis; | 2004 |
Transient hemifacial spasm associated with subarachnoid brainstem cysticercosis: a case report.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Brain Stem; Calcinosis; Evoked Potentials, Auditory, | 1998 |
[Cerebral cysticercosis and headache in a young Togolese woman].
Topics: Adult; Anthelmintics; Brain Diseases; Female; France; Headache; Humans; Neurocysticercosis; Praziqua | 2001 |